Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...

Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...